MCM3AP and urinary bladder carcinoma: In most cancers, the role and mechanism of action of MCM3AP-AS1 has been largely clarified, but it has not been studied in leukemia, multiple myeloma, gallbladder cancer, bladder cancer, esophageal cancer, and other cancers, and these are also directions for future research.